If you made any changes in Pure these will be visible here soon.

Research Outputs 2009 2018

  • 217 Citations
  • 9 h-Index
  • 13 Article
2018

A Brief, global history of microsimulation models in health: past applications, lessons learned and future directions

Schofield, D. J., Zeppel, M. J. B., Tan, O., Lymer, S., Cunich, M. M. & Shrestha, R. N., 1 Mar 2018, In : International Journal of Microsimulation. 11, 1, p. 97-142 46 p.

Research output: Contribution to journalArticleResearchpeer-review

Microsimulation
Health
Model
History
Model Error

Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness

Tan, O., Shrestha, R., Cunich, M. & Schofield, D. J., Mar 2018, In : Clinical Genetics. 93, 3, p. 533-544 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Cost-Benefit Analysis
Neoplasms
Mutation
Costs and Cost Analysis
MEDLINE
2016

A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner

Sutton, S. K., Carter, D. R., Kim, P., Tan, O., Arndt, G. M., Zhang, X. D., Baell, J., Noll, B. D., Wang, S., Kumar, N., McArthur, G. A., Cheung, B. B. & Marshall, G. M., 1 Aug 2016, In : Oncotarget. 7, 32, p. 52166-52178 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Melanoma
Small Molecule Libraries
PLX4032
Drug Combinations
Growth

High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients

Kim, P. Y., Tan, O., Liu, B., Trahair, T., Liu, T., Haber, M., Norris, M. D., Marshall, G. M. & Cheung, B. B., 1 May 2016, In : Cancer Letters. 374, 2, p. 315-323 9 p.

Research output: Contribution to journalArticleResearchpeer-review

DNA-Binding Proteins
Neuroblastoma
Breast Neoplasms
Growth
Neoplasms

Synthesis, characterization and anti-cancer activity of hydrazide derivatives incorporating a quinoline moiety

Bingul, M., Tan, O., Gardner, C. R., Sutton, S. K., Arndt, G. M., Marshall, G. M., Cheung, B. B., Kumar, N. & Black, D. S. C., 1 Jul 2016, In : Molecules. 21, 7, 19 p., 916.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
hydrazides
quinoline
cancer
Cells
Derivatives
2015

Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma

Cheung, B. B., Tan, O., Koach, J., Liu, B., Shum, M. S. Y., Carter, D. R., Sutton, S., Po'uha, S. T., Chesler, L., Haber, M., Norris, M. D., Kavallaris, M., Liu, T., O'Neill, G. M. & Marshall, G. M., 1 Aug 2015, In : Molecular Oncology. 9, 7, p. 1484-1500 17 p.

Research output: Contribution to journalArticleResearchpeer-review

Fenretinide
Thymosin
Neuroblastoma
Retinoids
Pharmaceutical Preparations
2014

Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach

Kim, P. Y., Tan, O., Diakiw, S. M., Carter, D., Sekerye, E. O., Wasinger, V. C., Liu, T., Kavallaris, M., Norris, M. D., Haber, M., Chesler, L., Dolnikov, A., Trahair, T. N., Cheung, N. K., Marshall, G. M. & Cheung, B. B., 16 Jan 2014, In : Journal of Proteomics. 96, p. 1-12 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Complement C3
Biomarkers
Neuroblastoma
Proteomics
Plasmas

TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells

Sutton, S. K., Koach, J., Tan, O., Liu, B., Carter, D. R., Wilmott, J. S., Yosufi, B., Haydu, L. E., Mann, G. J., Thompson, J. F., Long, G. V., Liu, T., McArthur, G., Zhang, X. D., Scolyer, R. A., Cheung, B. B. & Marshall, G. M., 1 Jan 2014, In : Oncotarget. 5, 20, p. 10127-10139 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Interferon-beta
Melanoma
Cell Movement
Melanocytes
Neoplasm Metastasis
2013

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

Calao, M., Sekyere, E. O., Cui, H. J., Cheung, B. B., Thomas, W. D., Keating, J., Chen, J. B., Raif, A., Jankowski, K., Davies, N. P., Bekkum, M. V., Chen, B., Tan, O., Ellis, T., Norris, M. D., Haber, M., Kim, E. S., Shohet, J. M., Trahair, T. N., Liu, T. & 3 othersWainwright, B. J., Ding, H. F. & Marshall, G. M., 1 Aug 2013, In : Oncogene. 32, 31, p. 3616-3626 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Protein Stability
Germ Cell and Embryonal Neoplasms
Oncogene Proteins
Neuroblastoma
Neoplasms

TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells

Kim, P. Y., Rahmanto, A. S., Tan, O., Norris, M. D., Haber, M., Marshall, G. M. & Cheung, B. B., 1 May 2013, In : Apoptosis. 18, 5, p. 639-651 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Caspase 2
Chemical activation
Cells
Apoptosis
Neoplasms
2012

The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro

Cheung, B. B., Koach, J., Tan, O., Kim, P., Bell, J. L., D'andreti, C., Sutton, S., Malyukova, A., Sekyere, E., Norris, M., Haber, M., Kavallaris, M., Cunningham, A. M., Proby, C., Leigh, I., Wilmott, J. S., Cooper, C. L., Halliday, G. M., Scolyer, R. A. & Marshall, G. M., Feb 2012, In : Journal of Pathology. 226, 3, p. 451-462 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Retinoids
Skin Neoplasms
Cell Movement
Squamous Cell Carcinoma
Carcinogenesis
2010

TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells

Marshall, G. M., Bell, J. L., Koach, J., Tan, O., Kim, P., Malyukova, A., Thomas, W., Sekyere, E. O., Liu, T., Cunningham, A. M., Tobias, V., Norris, M. D., Haber, M., Kavallaris, M. & Cheung, B. B., 18 Nov 2010, In : Oncogene. 29, p. 6172-6183 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Vimentin
Neuroblastoma
Retinoids
Neoplasms
Cell Movement
2009

The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation

Raif, A., Marshall, G. M., Bell, J. L., Koach, J., Tan, O., D'andreti, C., Thomas, W., Sekyere, E., Norris, M., Haber, M., Kavallaris, M. & Cheung, B. B., 8 May 2009, In : Cancer Letters. 277, 1, p. 82-90 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Retinoids
Acetylation
Histones
Estrogens
Neoplasms